DEA Administrator Terrance Cole has also signaled a tough line: "Everybody knows my stance on marijuana after 30 plus years in law enforcement, so don't even ask!" However, with all due respect to law enforcement, you can't fight a disease with a badge.
MMJ is developing FDA regulated medicine, not an illicit substance. We are the science, and our mission is to treat patients, not to police a plant." Duane Boise, CEO MMJ International Holdings.
Read More
Clinically Referenced Ingredients Like Glucomannan and Lactobacillus Acidophilus Help Support Healthy Blood Sugar Levels, Improve Digestion, and Promote Natural Energy Without Stimulants
Read More
Clinically studied dual‑action prostate support featuring Flowens™, Phytopin®, Graminex® G63®, and Lycopene for age‑related prostate health, emphasizing transparent sourcing and integration into long‑term wellness routines.
Read More
The Palace Company and Government of Jamaica Break Ground on Moon Palace The Grand - Montego Bay, a USD $700 Million Landmark Resort With Exclusive Benefits for Palace Elite Members
Read MoreMove comes amid increased demand for Sekur solutions from the crypto community targeted by cyber hackers worldwide
Read More
On Thursday, August 21st, ERP Advisors Group's ERP Expert to CEOs & CFOs, Shawn Windle, will evaluate why growing businesses should pursue a technology platform strategy to achieve ambitious growth.
Read More
Advancing Cubic's 60mm and 81mm LTS-Mortar systems from prototype to rapid fielding of indirect fire capabilities in the live training environment
Read More
A lawsuit is pending for certain investors in NASDAQ:NEOG shares over alleged securities laws violations by Neogen Corporation. Investors who purchased shares of Neogen Corporation (NASDAQ:NEOG) prior to January 2023 and continue to hold any of those NASDAQ:NEOG shares also have certain options and contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More
According to the NIH, Acute myocardial infarction (AMI) is a major cause of death, affecting nearly 3 million Americans each year and resulting in over a million deaths
Trial demonstrates dramatically higher and more rapid therapeutic impact compared to standard chewed aspirin tablets in clinical trial
Aspire's sublingual aspirin was safe and well-tolerated
Aspire plans to review clinical trial results with the FDA to enable a potential regulatory submission for accelerated approval
Apeiro will expand Ondas' capabilities into ground robotics and add fiber optic components for radio-independent UAV and UGV communications
Through mature platforms, strategic customer relationships, and an expected $12 million in 2025 revenues, Apeiro will accelerate operating scale and commercial reach
Acquisition demonstrates Ondas' commitment to leveraging its global operating platform to deliver a portfolio of advanced, AI-enabled capabilities to critical defense and security customers
Transaction is expected to close in the third quarter of 2025
Read MoreKingsway Search Xcelerator's 12th Acquisition
Asset-light plumbing services business with recurring revenues and leading market position
Purchase price of $5.625 million, plus a potential earn-out of up to $1.125 million, for a total maximum purchase price of $6.75 million
Unaudited pro-forma annual revenue of $4.0 million
Unaudited pro-forma annual adjusted EBITDA of $0.9 million
New credit facility to support growth at Kingsway Skilled Trades
